A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying potential.

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors, sleep ...

Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to ...

Parkinson’s disease (PD) is a growing global health challenge, affecting millions worldwide and imposing significant burdens ...

The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read ...

Throughout 2021 and 2022, researchers at Ghent University Hospital in Belgium watched with cautious optimism as nearly 50 people with early stage Parkinson’s disease visited the clinic as part of a ...

Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...

Results of a recent study strongly suggest simply getting more B vitamins in your diet could be a completely painless way of ...

People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...